Autonomix Medical Regains Nasdaq Compliance After 10-Day Bid-Price Streak
AMIX sits 59% above its 52-week low of $4.204 on light trading volume (0.2× avg).
Summary
Autonomix Medical has regained compliance with Nasdaq's $1.00 minimum bid-price rule after its stock closed at or above $1.00 for 10 consecutive business days from June 24 to July 8, 2026. This follows the 1-for-21 reverse stock split completed on June 24, which was specifically aimed at curing the deficiency. The Nasdaq letter confirms the matter is now closed, removing the immediate delisting threat that had been hanging over the stock since the going concern warning in the May 10-K. The resolution is a material positive for a micro-cap company with a market cap around $3.5 million, as it preserves its exchange listing and avoids the stigma and liquidity crunch of moving to the OTC markets.
At the time of this announcement, AMIX was trading at $6.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $4.20 to $55.44. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.